
Albicobal P 1500mcg/75mg Tablet SR
Marketer
Albia Biocare
Salt Composition
Methylcobalamin (1500mcg) + Pregabalin (75mg)
Overview Albicobal P 1500mcg/75mg Tablet SR
Gabapentinoid/pregabalin combination therapy (1500mcg/75mg sustained-release tablet) is a prescribed medication for managing neuropathic pain. It works by regulating nerve cell calcium channel function, thus reducing pain signals. This medication also supports nerve fiber health and facilitates nerve cell repair. Administer orally, with or without food, ideally at bedtime, consistently at the same time daily for optimal therapeutic levels. Follow your doctor's prescribed dosage and duration; this medication can be habit-forming. If a dose is missed, take it upon recollection. Complete the entire course, even with symptom improvement. Abrupt discontinuation is unsafe and requires prior physician consultation. Common side effects include upper respiratory infection, increased hunger, elevated mood, shaking, visual blurring, dry mouth, lightheadedness, and drowsiness. Avoid activities requiring concentration until the medication's effects are understood. Side effects are generally mild and improve over time. Weight gain is possible; counter this with regular exercise and a balanced diet. Report any unusual mood or behavioral shifts, new or worsening depression, or suicidal ideation to your doctor. Disclose all other medications to your doctor, as interactions can affect efficacy or mechanism. Notify your doctor of pregnancy, pregnancy plans, or breastfeeding.
Uses of Albicobal P 1500mcg/75mg Tablet SR
Managing neuropathic pain
Major Benefits of Albicobal P 1500mcg/75mg Tablet SR:
Administer this medication precisely as your physician directs, adhering to the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Albicobal P 1500mcg/75mg Sustained-Release Tablet can be consumed with or without food, though consistent timing is recommended.
Common Side effects of Albicobal P 1500mcg/75mg Tablet SR:
- Sleepiness
- Dizziness
- Nasopharyngitis (inflammation of the throat and nasal passages)
- Increased appetite
- Blurred vision
- Constipation
- Muscle cramp
- Edema (swelling)
- Erectile dysfunction
- Weight gain
- Balance disorder (loss of balance)
- Lethargy
- Vertigo
- Vomiting
- Headache
- Confusion
- Disorientation
- Abnormality of voluntary movements
How to use Albicobal P 1500mcg/75mg Tablet SR:
Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Albicobal P 1500mcg/75mg Sustained-Release tablets may be consumed with or without food, although consistent timing is recommended.
How Albicobal P 1500mcg/75mg Tablet SR works:
Albicobal P 1500mcg/75mg Extended-Release tablets contain methylcobalamin and pregabalin. Methylcobalamin, a vitamin B12 derivative, supports myelin sheath formation, protecting and repairing nerve cells. Pregabalin, acting as an alpha-2-delta calcium channel ligand, reduces pain signals by modulating nerve cell activity. This dual action provides effective relief from neuropathic pain.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent use of Albicobal P 1500mcg/75mg extended-release tablets and alcohol can lead to significant sleepiness.
PregnancyCONSULT YOUR DOCTOR
The use of Albicobal P 1500mcg/75mg Extended-Release Tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the potential advantages against any possible dangers prior to prescribing this medication. Seek medical advice before taking this medicine.
Breast feedingCONSULT YOUR DOCTOR
The extended-release Albicobal P 1500mcg/75mg tablet is likely not suitable for use while breastfeeding. Available human data indicates potential transfer to breast milk, posing a possible risk to the infant.
DrivingUNSAFE
Taking Albicobal P 1500mcg/75mg SR tablets can cause drowsiness, blurred vision, and dizziness. Refrain from driving if you experience these effects.
KidneyCAUTION
Patients with kidney impairment should use Albicobal P 1500mcg/75mg sustained-release tablets cautiously. Dosage modification of Albicobal P 1500mcg/75mg sustained-release tablets may be necessary. Physician consultation is advised.
LiverSAFE IF PRESCRIBED
The use of Albicobal P 1500mcg/75mg sustained-release tablets in patients with liver impairment is likely safe. Current evidence indicates dose modification may be unnecessary, however, physician consultation is recommended.
What if you forget to take Albicobal P 1500mcg/75mg Tablet SR :
Should you forget a dose of Albicobal P 1500mcg/75mg Extended-Release Tablet, take it immediately upon remembering. However, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Never take more than the prescribed dose.
Facts to Know About Albicobal P 1500mcg/75mg Tablet SR
| Label | Value |
|---|---|
| Addictive | None. |
| Medication Classification | Nervous System |
